Board of Directors
About Biopharmaceutical Innovation
Our Approach to Obesity Research
Events, Presentations, and Webcasts
Q & A About Clinical Trials
Meet Some of the Team
Health and Financial Benefits
OREXIGEN THERAPEUTICS, INC.
We are a biopharmaceutical company focused on the treatment of obesity...
Get to know our leadership team and learn about our collaborators...
WHO WE ARE
Meet the team and learn about exciting career opportunities at Orexigen...
INNOVATION DRIVES VALUE
We believe in the value of biopharmaceutical innovation and R&D as an important driver of improvements in patient health.
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.
Who We Are
"Orexigen has provided an opportunity that is more rewarding than I could have imagined..."
NEWS & ANNOUNCEMENTS
Takeda Pharmaceuticals and Orexigen Therapeutics Announce Termination of the Cardiovascular Outcomes Study (Light Study) of the Obesity Drug Contrave® (naltrexone HCl and bupropion HCl)
Click here for full Prescribing Information including BOXED WARNING »
Learn more about Contrave® »
Copyright© 2015 Orexigen Therapeutics, Inc. All rights reserved.
Terms & Conditions